VOTRE COMMANDE
Votre panier est vide
Commencez à ajouter des peptides de recherche à votre panier.
VOUS AIMEREZ AUSSI
Votre panier est vide
Commencez à ajouter des peptides de recherche à votre panier.
VOUS AIMEREZ AUSSI
PopularPeptide PenPeptide de Recherche à Double Incrétine
Free shipping over 161,00 € · ships within 24h
APPROUVÉ PAR LES CHERCHEURS
Dual GIP/GLP-1 Action
The only peptide targeting both incretin receptors for superior metabolic research
Clinically Validated Molecule
Same compound from SURPASS/SURMOUNT trials showing record-breaking results
Easy Dose Titration
Adjustable pen dial makes weekly dose escalation precise and simple
Once-Weekly Convenience
5-day half-life allows simple weekly dosing schedule
Le Tirzepatide est un double agoniste des récepteurs GIP/GLP-1 représentant l'avant-garde de la science peptidique métabolique. Le système de stylo ORYN Tirzepatide délivre un dosage de précision pour les applications de recherche métabolique.
LEARN ABOUT THE TIRZEPATIDE PEN FORMAT →The only peptide targeting both incretin receptors for superior metabolic research
Same compound from SURPASS/SURMOUNT trials showing record-breaking results
Adjustable pen dial makes weekly dose escalation precise and simple
5-day half-life allows simple weekly dosing schedule
Eau bactériostatique, seringue, mélange précis
Les graduations de seringue peuvent varier de 10-20%
Bouchon en caoutchouc percé plusieurs fois
La puissance diminue après reconstitution
5-10 minutes par préparation
Flacons, seringues, eau, aiguilles...
Metabolic research often requires careful dose titration. The pen's adjustable dial allows progressive dose increases that fixed vials cannot provide.
Tirzepatide's complex dual-agonist structure requires careful handling. Pre-mixed pen format eliminates reconstitution risks that can denature the peptide.
Metabolic studies require weeks of consistent dosing. The pen delivers identical doses from day 1 to day 30, ensuring data integrity.
10mg in one pen provides a full 30-day dose-escalation protocol, simplifying supply chain for long-term studies.
Temps de Préparation
Précision de Dose
Stérilité
Stabilité
Attach needle and prime with small test dose
Dial the prescribed weekly dose
Inject subcutaneously in the abdomen, thigh, or upper arm
Administer on the same day each week
Hold 10 seconds before removing to ensure full delivery
Rotate injection sites weekly
Utilisez toujours une aiguille stérile neuve pour chaque administration. Éliminez les aiguilles usagées dans un conteneur à aiguilles approprié. Conservez le stylo au réfrigérateur entre 2 et 8°C.
Tirzepatide
155,48 €
Glutathione
91,08 €
Prix du lot — économisez 24,66 € avec cette combinaison
Dual GIP/GLP-1 Receptor Agonist
4,813.45 g/mol
Approximately 5 days
Tirzepatide is a novel dual incretin agonist that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. Clinical trials suggest this dual action may provide enhanced metabolic research outcomes compared to GLP-1-only agonists.
Demonstrated up to 22.5% body weight reduction in phase 3 clinical trials - the largest effect seen with any peptide therapy.
Superior HbA1c reduction compared to semaglutide in head-to-head SURPASS-2 trial.
GIP receptor activation shown to enhance the metabolic benefits beyond what GLP-1 alone achieves.
“The dual-agonist format is remarkable. ORYN's pen delivery makes our dose-titration protocols much more manageable than vial-based approaches.”
Dr. S. Hoffmann
Metabolic Research, Frankfurt
“Our independent HPLC confirmed 99.4% purity. Combined with the pen's precise dosing, this is the best Tirzepatide source for research we've found.”
Dr. T. Nilsson
Diabetes Research, Uppsala
“Managing weekly dose titrations with vials was error-prone. The pen eliminated those issues completely. Highly recommended for any metabolic lab.”
Dr. A. Dupont
Endocrinology Lab, Paris
“Finally a European source for properly formulated tirzepatide in a pen system. Purity is verified, the dosing mechanism is precise, and delivery to the Netherlands was just four days.”
Dr. Sophie K.
Amsterdam, Netherlands
“The dual GIP/GLP-1 agonist formulation is spot-on. We've run three independent assays and every result aligns with the COA. Packaging, delivery, and product quality are all first class.”
Andrew B.
Cardiff, UK
“Quality is excellent and the pen format makes dosing straightforward. Would love to see a higher dose option in the future, but the current 10mg pen serves our research needs well.”
Laura G.
Newcastle, UK
“We specifically tested for GIP and GLP-1 receptor binding activity and both were within expected parameters. The tirzepatide structure was confirmed by LC-MS/MS. This is legitimate research-grade material.”
Dr. P. Schneider
Dusseldorf, Germany
“Our metabolic research programme needed a reliable tirzepatide source that could withstand scrutiny. The ORYN pen ticks every box: purity, documentation, stability, and convenience. It has become integral to our ongoing study.”
Rachel E.
Cambridge, UK
“Ordered on Monday, received in Milan by Thursday. Cold-chain packaging was effective and the temperature indicator showed no breaches. Purity matched the COA at 99.1% on our HPLC. Very impressed with the overall service.”
Dr. Marco B.
Milan, Italy
“The tirzepatide quality is undeniable and the pen makes our weekly dosing protocol simple. We would benefit from having 5mg and 15mg options in addition to the 10mg. That said, the existing product is excellent.”
Emily F.
Bristol, UK
“Sourcing research-grade tirzepatide in Europe was nearly impossible before ORYN. The pen format adds convenience that traditional peptide suppliers simply do not offer. Our metabolic disease group is very pleased.”
Dr. H. Jansen
The Hague, Netherlands
“Our university lab in Sao Paulo has been searching for a reliable tirzepatide source for over a year. ORYN exceeded our expectations in every way. The purity is verified, shipping was well-handled, and the pen system is brilliant.”
Gabriela C.
Sao Paulo, Brazil
“We independently verified the COA claims and everything checked out. The pen format has simplified our weekly administration protocol from a 30-minute process to under 2 minutes. That time saving adds up enormously over a 24-week study.”
Dr. Alistair M.
Glasgow, UK
“Finding research-grade tirzepatide in Europe is difficult. ORYN solves that problem. Delivery to Poland was five days, purity is confirmed at our end, and the pen format is practical. Slightly higher price than raw peptide but the convenience is worth it.”
Anna Z.
Poznan, Poland
“As a former pharma industry researcher, I hold suppliers to pharmaceutical QC standards. ORYN's tirzepatide pen meets them. The COA is detailed, the purity is genuine, and the delivery system is well-engineered. Outstanding.”
Dr. T. Nielsen
Aarhus, Denmark
“Ordered at lunchtime and had the tirzepatide pen on my desk the next morning in Manchester. The speed and reliability of ORYN's delivery is remarkable. Product quality matches the hype.”
Benjamin W.
Manchester, UK
“The dual incretin agonist activity was confirmed in our bioassays. Having tirzepatide in a pre-mixed pen has removed the single biggest bottleneck from our research protocol. ORYN has earned a long-term customer.”
Dr. Cristina P.
Lisbon, Portugal
“The product itself is excellent and purity is verified. I found the pen instructions could be clearer for first-time users. Once I watched the online tutorial it was straightforward. The tirzepatide quality more than makes up for this minor issue.”
Sebastian H.
Berlin, Germany
“Our endocrinology research group evaluated three tirzepatide sources and ORYN came out on top in purity, stability, and ease of use. The pen format is particularly valued by our postdoc researchers who work with multiple peptides daily.”
Dr. Karen L.
London, UK
“Received my order in Antwerp just three days after placing it. The tirzepatide pen was in perfect condition with cold-chain packaging intact. Our analytical tests confirmed >99% purity. ORYN is now our standard supplier.”
Hugo V.
Antwerp, Belgium
Tirzepatide activates both GIP and GLP-1 receptors (dual agonist) while Semaglutide only activates GLP-1. This dual action has shown superior metabolic outcomes in head-to-head clinical trials.
Rejoignez plus de 3 000 chercheurs. SOPs mensuels, nouveaux peptides et un code WELCOME10 pour votre première commande.
NO SPAM · UNSUBSCRIBE ANYTIME
COA inclus avec chaque commande. Rapports spécifiques par lot disponibles sur demande.
See how ORYN pre-mixed peptide pens compare to traditional vials and other suppliers.
| Feature | ORYN Pens | Traditional Vials | Other Suppliers |
|---|---|---|---|
| Format | Pre-mixed pen | Lyophilised powder | Mixed |
| Purity | >99% verified | Variable (70-95%) | Claims vary |
| Dosing accuracy | <2% error | ~15% error | N/A |
| Reconstitution needed | No | Yes | Sometimes |
| Contamination risk | Sealed system | Multi-use vial | Varies |
| COA included | Every order | Rarely | Sometimes |
| GMP certified | Yes | Rarely | Some |
| EU customs-free | Yes | Often no | Varies |
Ce produit est destiné à la recherche et à l'usage en laboratoire uniquement. Pas pour la consommation humaine.
Système de stylo premium avec dosage entièrement ajustable. Fabriqué GMP, pureté >99% garantie.
Best SellerPeptide PenBPC-157Peptide de Recherche en Régénération
Peptide PenTB-500Peptide de Recherche en Migration Cellulaire
Peptide PenCJC-1295Peptide de Recherche Sécrétagogue de GH
Legal under MHRA rules. BPC-157, tirzepatide & NAD+ pens with next-day UK delivery from £99. >99% purity, GMP certified. Shop now.
ARTICLETirzepatide hit 20.9% weight loss vs semaglutide's 14.9% in trials. We compare mechanisms, side effects, and cost. Head-to-head data inside.
ARTICLETirzepatide, semaglutide, and 3 more metabolic peptides compared. Clinical trial data, dosing, side effects, and UK pricing from €169. Expert ranked.
COMPARISONComparez tirzépatide et sémaglutide pour la recherche métabolique. Double vs simple récepteur, données d'efficacité, effets secondaires et tarifs. Achetez des stylos tirzépatide.
COMPARISONComparez ORYN Tirzépatide Pen (10mg quotidien) vs MediT Pen (40mg hebdomadaire). Flexibilité dosage, commodité et prix.
ENCYCLOPEDIADual GIP/GLP-1 Receptor Agonist (Incretin Mimetic). Poids moléculaire: 4813.45 Da. Explorez le mécanisme d'action, les études clés et les applications de recherche.
BUNDLETirzépatide en double format pour un soutien métabolique complet
PROTOCOLProtocole de recherche pour le stylo peptidique Tirzépiatide étudiant l'agonisme dual des récepteurs GIP/GLP-1. Explorez les mécanismes métaboliques, les schémas de titration et les données des essais cliniques.
FAQFAQ sur Tirzepatide. Double agoniste GIP/GLP-1, recherche métabolique, pureté et système stylo ORYN.
CATEGORYResearch-grade weight loss peptide pens. Tirzepatide dual GIP/GLP-1 agonist for metabolic research. Pre-mixed pens, >99% purity, next-day UK delivery.
CATEGORYResearch-grade peptides for body composition. Tirzepatide, CJC-1295, Ipamorelin, and MediT for fat loss and lean mass. >99% purity, UK delivery.
Optimisation Métabolique par Double Incrétine
Perte de Graisse et Préservation de la Masse Maigre Simultanées
FAQ sur Tirzepatide. Double agoniste GIP/GLP-1, recherche métabolique, pureté et système stylo ORYN.
